GI
HAE icon

GAMMA Investing’s Haemonetics HAE Stock Holding History

GAMMA Investing’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.2K Buy
803
+459
+133% +$29.5K ﹤0.01% 2176
2026
Q1 		$19.4K Buy
344
+90
+35% +$5.86K ﹤0.01% 2727
2025
Q4 		$20.4K Buy
254
+130
+105% +$8.73K ﹤0.01% 2608
2025
Q3 		$6.04K Sell
124
-319
-72% -$19.7K ﹤0.01% 3096
2025
Q2 		$33.1K Buy
443
+165
+59% +$10.9K ﹤0.01% 2181
2025
Q1 		$17.7K Buy
278
+122
+78% +$8.3K ﹤0.01% 2462
2024
Q4 		$12.2K Buy
156
+62
+66% +$4.98K ﹤0.01% 2508
2024
Q3 		$7.56K Sell
94
-43
-31% -$3.47K ﹤0.01% 2568
2024
Q2 		$11.3K Buy
137
+109
+389% +$9.59K ﹤0.01% 2181
2024
Q1 		$2.39K Sell
28
-31
-53% -$2.43K ﹤0.01% 2698
2023
Q4 		$4.51K Buy
+59
New +$5.1K ﹤0.01% 2287

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GAMMA Investing's HAE Position: Q2 2026 in Review

GAMMA Investing increased its Haemonetics (HAE) stake by 133% in Q2 2026, buying an estimated $29.5K and bringing the position to 803 shares worth $60.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2176.

GAMMA Investing first reported a position in HAE in Q4 2023 and has held it in 11 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • GAMMA Investing held 803 shares of Haemonetics worth $60.2K as of Q2 2026.
  • GAMMA Investing bought 459 Haemonetics shares in Q2 2026, an estimated $29.5K.
  • Haemonetics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2176 holding.
  • GAMMA Investing first reported a position in Haemonetics in Q4 2023 and has held it in 11 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.